This edition of the Carnival of Biotechnology features commentary on regulatory problems and progress, international development, and failed commercialization strategies. Regulatory The Washington Post has a report from the Institute of Medicine claiming that the drug review system is broken, and calling for changes. The Patent Barista’s update the road to biogenerics, profiling recent bills […]
Welcome to this week’s edition of the Carnival of Biotechnology. Some pretty good stuff this week. More Vioxx news, the human genome stops by for an update, and no love for the FDA. Finance SignalsMag provides an update on March financials: Modest Gains, Solid Quarter. Regulation The Drug Wonks take a Dumb and Dumber approach […]
This week’s edition of the Carnival of Biotechnology addresses a number of issues challenging the biotechnology industry today. Innovation About biotech proclaims Innovation is dead, long live innovation! in the wake of Proctor & Gamble’s spin of the dissolution of it’s pharma R&D efforts as a bold new innovation strategy. A Vc asks changing our […]
The latest carnival of biotechnology has been posted at Patent Baristas. Check it out for a fresh outlook on issues driving the industry today.
Welcome to this edition of the Carnival of Biotechnology. The next edition will be hosted at Patent Baristas. If you’re interested in hosting the Carnival, drop an email to email@example.com. General Business While not technically a blog post, this article from CNN highlights an oft-ignored element of biotechnology, supplying laboratories. Raising lab animals is big […]
Welcome to the inaugural Carnival of Biotechnology. This roundup of the best blogs on biotechnology brings together the best posts covering the industry. This week’s carnival is hosted here at Biotechblog.com. The next post will be at About.com Biotechnology. For more information about the Carnival of Biotechnology, see the Carnival’s homepage. Without further ado, here’s […]
The Carnival of Biotechnology is a regular roundup of the best blog posts on biotechnology. The carnival is guest-hosted by different sites, ensuring diversity in content and viewpoints. Check out the info page and submit your article or sign up to host the carnival.
After much frustration with the previous blog host for BiotechBlog, we’ve now moved to a new home at WordPress. Initial reactions are quite positive. Hope you like the new design.
This blog post and the ensuing discussion present an interesting and revealing dialogue on the practicality of creating an open marketplace for biotech patents; the benefits of open-licensing must be weighed against the high capital and time requirements for vetting and development.
HGS recently completed a $225 million factory to make products that still don’t exist…